z-logo
Premium
There is still a place for tumour‐targeted therapies in Merkel cell carcinoma in the era of immune checkpoint inhibitors
Author(s) -
Samimi M.,
Becker J.
Publication year - 2021
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.19247
Subject(s) - merkel cell carcinoma , medicine , immune checkpoint , merkel cell , cancer research , oncology , immune system , carcinoma , immunotherapy , immunology
Linked Article:   Akaike et al. Br J Dermatol 2021; 184 :319–327.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom